"This puts the Company in a better position to attract cost-effective, less dilutive capital while simultaneously demonstrating the long term commitment and support our insiders and affiliates have for the Company by preventing further dilution to the rest of the Company’s shareholders”, commented Lorraine Yarde, Rx Safes’ Chief Executive Officer."
For those who have been here a while and witness to your rxsf posts, where you spend an inordinate amount of time on a stock you don't own, we know exactly what your intensions are with your posts...